Marshall Crew and Joe Principe will be presenting in the Speaker’s Corner on Oct. 14.
At this year’s CPhI, experts from Patheon will be presenting at the Speaker’s Corner on Wednesday, Oct. 14. At noon, Marshall Crew, PhD, vice president, global PDS scientific excellence, will discuss how to optimize solubilization strategies and unlock the potential of promising drugs in his presentation, “The Story of Solubilization: New Data and Insights on the Past and What Lies Ahead.”
Low solubility is a growing issue in the successful development of pharmaceutical products, and solubility outcomes can be unpredictable. Crew will explore the scientific expertise that is required to ensure success for these increasingly complex formulations, and the multiple technologies available to address solubility.
In addition, Joe Principe, vice president of global alliance accounts, will present “Mitigating Uncertainty in Demand Forecasting with Flexible Capacity Solutions” at 2:30 p.m. Pharmaceutical companies develop forecasts to estimate future needs, but predicting performance in a market filled with competing products that do not yet exist is problematic. Principe will discuss several ways to provide cost-effective flexible manufacturing capacity.
Patheon executives, technical and scientific experts attending CPhI/ICSE Worldwide will be available to discuss the company’s full services and capabilities at booth 3F10.
Source: Patheon, Booth 3F10
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.